Physician profile
Scott B Taylor
NPI 1871539148
$17,844.74
in general payments reported to CMS, 2019-2025
31 companies · $1,279 in 2025
The $1,279 reported for 2025 was more than what 90% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,323 · 2020: $4,662 · 2021: $6,400 · 2022: $1,897 · 2023: $1,521 · 2024: $763 · 2025: $1,279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,562.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $10,472.58 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, General - Therapies |
| Abbott Laboratories | $3,780.87 | 2019-2025 | Proclaim, Eterna |
| Medtronic, INC. | $802.51 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Nevro Corp. | $608.11 | 2019-2024 | Senza |
| Vertos Medical, INC. | $486.34 | 2022-2023 | Mild Device Kit |
| Pacira Therapeutics, INC. | $361.80 | 2019-2021 | |
| Mml US, INC. | $293.09 | 2023-2025 | Reactiv8 |
| Medtronic USA, INC. | $175.36 | 2019 | |
| Bioventus LLC | $109.32 | 2019-2022 | |
| Glaxosmithkline, LLC. | $96.24 | 2019-2020 | |
| Pfizer INC. | $68.44 | 2019-2021 | |
| Vertiflex, INC. | $54.94 | 2019 | |
| Spinal Simplicity, LLC | $49.72 | 2025 | Ha Minuteman G3-R |
| Averitas Pharma INC. | $46.94 | 2023 | Qutenza |
| Ironshore Pharmaceuticals INC. | $44.92 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $44.89 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $40.88 | 2025 | |
| Grt US Holding, INC. | $40.05 | 2022 | |
| Abbvie INC. | $37.43 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $31.39 | 2023 | |
| Sanofi Pasteur INC. | $26.75 | 2024 | |
| Allergan, INC. | $26.37 | 2020 | |
| Globus Medical, INC. | $22.43 | 2025 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.34 | 2025 | Xifaxan |
| Neos Therapeutics, LP | $17.15 | 2019 | |
| Ethicon US, LLC | $17.07 | 2022 | |
| Nalu Medical, INC. | $15.05 | 2024 | Nalu Neurostimulation System |
| Pacira Pharmaceuticals Incorporated | $14.95 | 2023 | Zilretta, Exparel, Iovera |
| Avanos Medical | $14.92 | 2023 | Generator |
| Supernus Pharmaceuticals, INC. | $14.79 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $12.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.